Your search for major depressive disorder returned 4 results

Individuals with relapsing-remitting MS who respond suboptimally to DMT may experience improvement with the addition of an SSRI.

Researchers sought to assess outcomes in hospitalized patients with comorbid Parkinson disease and major depressive disorder following administration of deep brain stimulation.

The system is currently being assessed for its use in stroke rehabilition in the Phase 3 supplemental study ‘E-FIT’, involving 60 patients.

Changes to brain structure indicate possible underlying connection to idiopathic major depressive disorder.